Article Details
Retrieved on: 2021-12-07 11:34:49
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
British drugmaker GSK said on Tuesday its antibody-based COVID-19 therapy with U.S. partner Vir Biotechnology is effective against all mutations ...
Article found on: www.reuters.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here